OTC Markets Group Inc. (OTCM: OTCQX U.S. Premier) | OTC Markets Group Welcomes ChromaDex to OTCQX®


NEW YORK, Nov. 10, 2014 /PRNewswire/ — OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced ChromaDex Inc. (OTCQX: CDXC), an innovative natural products company, has qualified to trade on OTCQX®, the best marketplace.

Logo – http://photos.prnewswire.com/prnh/20110118/MM31963LOGO

ChromaDex begins trading today on OTCQX under the symbol “CDXC.”  U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.

“We are proud to welcome ChromaDex to the OTCQX marketplace,” said R. Cromwell Coulson, President and CEO of OTC Markets Group.  “ChromaDex joins the growing group of U.S. and global companies that are choosing to trade on OTCQX to provide their investors transparent trading and convenient access to their news and financial disclosure.  We congratulate ChromaDex’s management team on this achievement and wish the company continued success.”

Commenting on the announcement, Frank Jaksch, co-Founder and CEO of ChromaDex stated, “Having our common shares trade on OTCQX should improve our visibility in the public markets, help us expand our shareholder base, narrow bid/ask spreads and enhance liquidity.  It will also increase investors’ transparency in trading and provide increased access to news and disclosures.”  

Sichenzia Ross Friedman Ference LLP serves as ChromaDex’s Designated Advisor for Disclosure (“DAD”) on OTCQX, responsible for providing professional guidance on OTCQX requirements and U.S. securities laws.

ChromaDex is an innovative natural products company that discovers, acquires, develops and commercializes proprietary-based ingredient technologies through its unique business model that utilizes its wholly owned synergistic business units.  These units include the supply of phytochemical reference standards, which are small quantities of plant-based compounds typically used to research an array of potential attributes, and reference materials, related contract services, and proprietary ingredients.  It performs chemistry-based analytical services at its laboratory in Boulder, Colorado, typically in support of quality control or quality assurance activities within the dietary supplement industry.  Through its subsidiary Spherix Consulting, Inc., Chromadex also provides scientific and regulatory consulting to the clients in the food, supplement and pharmaceutical industries to manage potential health and regulatory risks.

About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities.  Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities.  We organize these securities into marketplaces to better inform investors of opportunities and risks – OTCQX®, The Best Marketplace; OTCQB®, The Venture Marketplace; and OTC Pink®, The Open Marketplace.  Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors.  To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.

OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.

Subscribe to the OTC Markets RSS Feed

Media Contact:
Saskia Sidenfaden, OTC Markets Group Inc., +1 (212) 896-4428, saskia@otcmarkets.com

SOURCE OTC Markets Group Inc.

Leave a Reply